Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) FCF Margin (2020 - 2025)

Historic FCF Margin for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 23.7%.

  • Treace Medical Concepts' FCF Margin rose 89100.0% to 23.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.04%, marking a year-over-year increase of 92600.0%. This contributed to the annual value of 23.29% for FY2024, which is 13100.0% up from last year.
  • Latest data reveals that Treace Medical Concepts reported FCF Margin of 23.7% as of Q3 2025, which was up 89100.0% from 16.5% recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' FCF Margin registered a high of 1.25% during Q1 2025, and its lowest value of 52.5% during Q2 2022.
  • Moreover, its 5-year median value for FCF Margin was 23.7% (2025), whereas its average is 24.86%.
  • Per our database at Business Quant, Treace Medical Concepts' FCF Margin tumbled by -310800bps in 2022 and then skyrocketed by 230600bps in 2025.
  • Treace Medical Concepts' FCF Margin (Quarter) stood at 13.91% in 2021, then decreased by -11bps to 15.43% in 2022, then soared by 82bps to 2.76% in 2023, then plummeted by -284bps to 10.6% in 2024, then plummeted by -124bps to 23.7% in 2025.
  • Its last three reported values are 23.7% in Q3 2025, 16.5% for Q2 2025, and 1.25% during Q1 2025.